Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ImmunityBio
AddedFeb 19, 2024
UpdatedJun 18, 2026
ImmunityBio

ImmunityBio

Public

ImmunityBio: A biotech firm innovating cell and immunotherapy products to enhance natural immunity against diseases.

HQ
San Diego, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

ImmunityBio is a biotech firm focused on developing innovative cell and immunotherapy products aimed at enhancing the natural immune system to combat diseases, including cancer. The company’s mission is to empower the immune system to outsmart and eliminate cancerous or infected cells. ImmunityBio is committed to increasing diversity in clinical trials to ensure that results help reduce healthcare disparities. Founded by Dr. Patrick Soon-Shiong, the company is dedicated to pioneering new frontiers in immunotherapy.

ImmunityBio has achieved significant milestones, including collaborations with the Serum Institute of India to manufacture BCG at a large scale and advancements in treatments for non-muscle invasive bladder cancer. Dr. Patrick Soon-Shiong, a notable figure in biotechnology, leads the company. ImmunityBio's efforts in diversifying clinical trial participation and its innovative approaches have positioned it as a key player in the biotech industry, striving to make impactful changes in healthcare.

ImmunityBio - Similar Companies

Nantkwest logo

Nantkwest

INmune Bio logo

INmune Bio

inmunebio.com

Immunome logo

Immunome

Immuneering logo

Immuneering

immuneering.com

Inimmune logo

Inimmune

inimmune.com

HI-Bio logo

HI-Bio

hibio.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

ImmuneBridge logo

ImmuneBridge

immunebridge.com

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

Imunon logo

Imunon

imunon.com

ImmuCision Biotherapeutics logo

ImmuCision Biotherapeutics

Cleveland BioLabs logo

Cleveland BioLabs

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Immunicom logo

Immunicom

immunicom.com

ImmunityBio - Quick Facts

Who are ImmunityBio's competitors?

Companies similar to ImmunityBio include Nantkwest, INmune Bio, Immunome and Immuneering.

When was ImmunityBio founded?

ImmunityBio was founded in 2014.

Where is ImmunityBio's headquarters located?

ImmunityBio's headquarters is located in San Diego, CA, US.

When was ImmunityBio's last funding round?

ImmunityBio's most recent funding round was for $10M (USD) in January 2024.

How much has ImmunityBio raised to-date?

As of Jan 2, 2024, ImmunityBio has raised a total of $1.1B (USD).

How many employees does ImmunityBio have?

ImmunityBio has 587 employees as of Feb 6, 2024.

ImmunityBio - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
  • Immunotherapy
Tags
  • Healthtech
Unique IDs
  • ein: 431979754
  • secCik: 0001326110
  • ticker: IBRX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research